Drug Profile
Research programme: melatonin receptor modulators - Lundbeck
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Lundbeck Research USA
- Class Amides; Piperidines
- Mechanism of Action Melatonin receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Circadian rhythm sleep disorders; Sleep disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Circadian rhythm sleep disorders in USA
- 16 Jul 2016 No recent reports of development identified for preclinical development in Sleep-disorders in USA
- 17 Nov 2010 Preclinical trials in Circadian rhythm sleep disorders in USA (unspecified route)